Literature DB >> 10491017

Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549).

M V Croce1, A G Colussi, M R Price, A Segal-Eiras.   

Abstract

The morphology, cell growth, antigenic expression and tumorigenicity of cell subpopulations from the A549 lung adenocarcinoma isolated by Percoll gradient separation have been analysed. Four subpopulations were obtained (subpopulations A, B, C and D). Immunocytochemical analysis of several antigens was performed with monoclonal antibodies (MAbs): MUC1 mucin (C595, HMFG1 and HMFG2), MUC5B (PANH2); gp230 (PANH4); carbohydrate antigens including sialyl Lewis x (KM93), Tn antigen (83D4), Lewis y (C14); 5, 6, 8, 17 and 19 cytokeratins and p53. The cell population D tended to form cell aggregates that piled up on the monolayer similar to overgrowth cultures of the A549 parental cell line, whereas A, B and C cell subpopulations formed well spread monolayers. Both parental A549 and subpopulation D secreted abundant mucus. The topographic distribution and secretion production were correlated with tumorigenic assays since only subpopulation D grew in nude mice exhibiting reduced latency period; these characteristics correlated with the fast growth of the subpopulation D in vitro. Immunocytochemical analysis demonstrated that subpopulation D showed greater expression of MUC1 mucin and carbohydrate antigens such as Tn antigen, sialyl Lewis x and Lewis y and less expression of cytokeratins, p53, MUC5B and gp230; conversely, subpopulations A, B and C showed the opposite antigenic profile. Our results illustrate heterogeneity in the A549 cell line; subpopulations A, B and C retained characteristics of more differentiated adenocarcinoma while subpopulation D displayed features of a less differentiated tumor line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491017     DOI: 10.1053/paor.1999.0212

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  38 in total

1.  Loss of a novel mucin-like epithelial glycoprotein in oral and cervical squamous cell carcinomas.

Authors:  P A Nielsen; U Mandel; M H Therkildsen; V Ravn; L David; C A Reis; H H Wandall; E Dabelsteen; H Clausen
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

2.  A monoclonal antibody against human colonic adenoma recognizes difucosylated Type-2-blood-group chains.

Authors:  A Brown; T Feizi; H C Gooi; M J Embleton; J K Picard; R W Baldwin
Journal:  Biosci Rep       Date:  1983-02       Impact factor: 3.840

3.  Mutant isolation.

Authors:  L H Thompson
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  Establishment and characterization of a human lung adenocarcinoma cell line (LC-2/ad) producing alpha 1-antitrypsin in vitro.

Authors:  H Kataoka; H Itoh; K Seguchi; M Koono
Journal:  Acta Pathol Jpn       Date:  1993-10

5.  Expression of blood group antigens by normal bronchopulmonary tissues and common forms of pulmonary carcinomas.

Authors:  E Alvarez-Fernandez; L Carretero-Albiñana
Journal:  Arch Pathol Lab Med       Date:  1991-01       Impact factor: 5.534

6.  Characterization of quantitative mucin variants from a human colon cancer cell line.

Authors:  S F Kuan; J C Byrd; C B Basbaum; Y S Kim
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

7.  Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.

Authors:  S Hirohashi; H Clausen; T Yamada; Y Shimosato; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

8.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

9.  Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells.

Authors:  Y Izumi; Y Taniuchi; T Tsuji; C W Smith; S Nakamori; I J Fidler; T Irimura
Journal:  Exp Cell Res       Date:  1995-01       Impact factor: 3.905

10.  Spontaneous changes in intermediate filament protein expression patterns in lung cancer cell lines.

Authors:  J L Broers; M K Rot; T Oostendorp; G Bepler; L De Leij; D N Carney; G P Vooijs; F C Ramaekers
Journal:  J Cell Sci       Date:  1988-09       Impact factor: 5.285

View more
  19 in total

Review 1.  Lewis x is highly expressed in normal tissues: a comparative immunohistochemical study and literature revision.

Authors:  María V Croce; Marina Isla-Larrain; Martín E Rabassa; Sandra Demichelis; Andrea G Colussi; Marina Crespo; Ezequiel Lacunza; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

2.  Breast cancer cells evade paclitaxel-induced cell death by developing resistance to dasatinib.

Authors:  Yun-Ji Jeong; Jong Soon Kang; Su In Lee; Dong Min So; Jieun Yun; Ji Young Baek; Sang Kyum Kim; Kiho Lee; Song-Kyu Park
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

3.  NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release.

Authors:  Erik P Lillehoj; Sang Won Hyun; Anguo Liu; Wei Guang; Avelino C Verceles; Irina G Luzina; Sergei P Atamas; K Chul Kim; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2015-05-11       Impact factor: 5.157

4.  Reductive activation of hexavalent chromium by human lung epithelial cells: generation of Cr(V) and Cr(V)-thiol species.

Authors:  Griselda R Borthiry; William E Antholine; Judith M Myers; Charles R Myers
Journal:  J Inorg Biochem       Date:  2008-01-08       Impact factor: 4.155

5.  Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells.

Authors:  Adam Szadkowski; Charles R Myers
Journal:  Toxicology       Date:  2007-10-10       Impact factor: 4.221

6.  Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins.

Authors:  Anna Litwiniec; Alina Grzanka; Anna Helmin-Basa; Lidia Gackowska; Dariusz Grzanka
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-07       Impact factor: 4.553

7.  The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells.

Authors:  Charles R Myers; Judith M Myers
Journal:  Toxicology       Date:  2008-12-24       Impact factor: 4.221

8.  MUC1 aptamer-based near-infrared fluorescence probes for tumor imaging.

Authors:  Haiyan Chen; Juan Zhao; Min Zhang; Haibo Yang; Yuxiang Ma; Yueqing Gu
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

9.  Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.

Authors:  Tatiana A Reimer; Ioannis Anagnostopoulos; Bettina Erdmann; Insa Lehmann; Harald Stein; Peter Daniel; Bernd Dörken; Armin Rehm
Journal:  BMC Cancer       Date:  2005-05-17       Impact factor: 4.430

10.  Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells.

Authors:  Bernhard B Singer; Inka Scheffrahn; Robert Kammerer; Norbert Suttorp; Suleyman Ergun; Hortense Slevogt
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.